EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin

Anna Hucke, Rita Schröter, Cecilia Ceresa, Alessia Chiorazzi iD, Annalisa Canta, Sara Semperboni, Paola Marmiroli iD, Guido Cavaletti iD, Burkhard Gess, Giuliano Ciarimboli iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Hucke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Experimentelle Nephrologie, Medizinische Klinik D, Universitätsklinikum Münster, 48149 Münster, Germany. Hauptthemen laut MEDLINE: Cisplatin, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Italian Ministry of University and Research, German Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (CDDP) is an efficient chemotherapeutic agent broadly used to treat solid cancers. Chemotherapy with CDDP can cause significant unwanted side effects such as renal toxicity and peripheral neurotoxicity. CDDP is a substrate of organic cation transporters (OCT), transporters that are highly expressed in renal tissue. Therefore, CDDP uptake by OCT may play a role in causing unwanted toxicities of CDDP anticancer treatment. In this study, the contribution of the mouse OCT2 (mOCT2) to CDDP nephro- and peripheral neurotoxicity was investigated by comparing the effects of cyclic treatment with low doses of CDDP on renal and neurological functions in wild-type (WT) mice and mice with genetic deletion of OCT2 (OCT2−/− mice). This CDDP treatment protocol caused significant impairment of kidneys and peripherical neurological functions in WT mice. These effects were significantly reduced in OCT2−/− mice, however, less profoundly than what was previously measured in mice with genetic deletion of both OCT1 and 2 (OCT1-2−/− mice). Comparing the apparent affinities (IC50) of mOCT1 and mOCT2 for CDDP, the mOCT1 displayed a higher affinity for CDDP than the mOCT2 (IC50: 9 and 558 µM, respectively). Also, cellular toxicity induced by incubation with 100 µM CDDP was more pronounced in cells stably expressing mOCT1 than in cells expressing mOCT2. Therefore, in mice, CDDP uptake by both OCT1 and 2 contributes to the development of CDDP undesired side effects. OCT seem to be suitable targets for establishing treatment protocols aimed at decreasing unwanted CDDP toxicity and improving anticancer treatment with CDDP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug-Related Side Effects and Adverse ReactionsAnimalsMiceBiological TransportKidneyOrganic Cation Transport ProteinsOrganic Cation Transporter 2Catecholamine Plasma Membrane Transport Proteins

Stichwörter der Autor:innen

cisplatindorsal root gangliakidneysperipheral neurotoxicitytoxicitytransporters

Substanzen

CisplatinOrganic Cation Transport ProteinsOrganic Cation Transporter 2Slc22a1 protein, mouseCatecholamine Plasma Membrane Transport ProteinsSlc22a2 protein, mouse

Autor:innen und Institutionen

  • Experimentelle Nephrologie, Medizinische Klinik D, Universitätsklinikum Münster, 48149 Münster, Germany.
  • Experimental Neurology Unit, Department of Medicine and Surgery, University of Milano Bicocca, 20900 Monza, Italy.
  • Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
  • Department of Neurology, University Hospital Münster, 48149 Münster, Germany.
  • Department of Neurology, Evangelisches Klinikum Bethel, University of Bielefeld, 33617 Bielefeld, Germany.

ORCID-Profile: Alessia Chiorazzi, Paola Marmiroli, Guido Cavaletti, Giuliano Ciarimboli

Förderung

  • Deutsche Forschungsgemeinschaft
  • Italian Ministry of University and Research
  • German Research Council

Zitieren

APA

Hucke, A., Schröter, R., Ceresa, C., Chiorazzi, A., Canta, A., Semperboni, S., Marmiroli, P., Cavaletti, G., Gess, B., & Ciarimboli, G. (2023). Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411486

Vancouver

Hucke A, Schröter R, Ceresa C, Chiorazzi A, Canta A, Semperboni S, et al. Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411486

BibTeX
@article{Hucke2023,
  author = {Hucke, Anna and Schröter, Rita and Ceresa, Cecilia and Chiorazzi, Alessia and Canta, Annalisa and Semperboni, Sara and Marmiroli, Paola and Cavaletti, Guido and Gess, Burkhard and Ciarimboli, Giuliano},
  title = {Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411486}
}
Kostenlos starten →